Condition category
Mental and Behavioural Disorders
Date applied
04/04/2006
Date assigned
04/04/2006
Last edited
18/08/2009
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Dr J.E. Jacobs

ORCID ID

Contact details

University Medical Center St Radboud
Center for Quality of Care Research (WOK)
P.O. Box 9101
Nijmegen
6500 HB
Netherlands
+31 (0)24 3615310
j.jacobs@kwazo.umcn.nl

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

NTR614

Study information

Scientific title

Acronym

TAPS

Study hypothesis

The intervention increases advice given by dental professionals, the number of patients having quit smoking and the number of quit attempts.

Ethics approval

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Treatment

Patient information sheet

Condition

Tobacco addiction

Intervention

Provision of a 4 hour central course for whole practice teams, patient-mediated monitoring and feedback of the provision of cessation advice, patient education materials and a task organisation protocol for the various members of the dental team.
The dental teams in the control group deliver usual care.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Patient-reported number of smoking cessation advice given by the dental team, patients' smoking status and quit attempts.

Secondary outcome measures

Professionals' attitudes towards smoking and smoking cessation support, their knowledge of health consequences of smoking tobacco (especially dental health), patients' perspectives of smoking cessation.
Support by dentists will be measured as well as self-efficacy to provide smoking cessation support.

Overall trial start date

01/01/2006

Overall trial end date

01/11/2008

Reason abandoned

Eligibility

Participant inclusion criteria

Smoking patients visiting dental practices.

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

1300

Participant exclusion criteria

Patients under the age of 18.

Recruitment start date

01/01/2006

Recruitment end date

01/11/2008

Locations

Countries of recruitment

Netherlands

Trial participating centre

University Medical Center St Radboud
Nijmegen
6500 HB
Netherlands

Sponsor information

Organisation

University Medical Center St Radboud, Center for Quality of Care Research (WOK) (The Netherlands)

Sponsor details

117 KWAZO
P.O. Box 9101
Nijmegen
6500 HB
Netherlands

Sponsor type

Not defined

Website

Funders

Funder type

Industry

Funder name

Pfizer (Netherlands)

Alternative name(s)

Pfizer Inc.

Funding Body Type

private sector organisation

Funding Body Subtype

corporate

Location

United States of America

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes